| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/13/2023 | -33.9% | Alliance Global Partners | $0.12 → $0.07 | Maintains | Neutral |
| 01/24/2023 | 1316.43% | Alliance Global Partners | $2.2 → $1.5 | Maintains | Neutral |
| 10/14/2022 | 2260.72% | Canaccord Genuity | $12.5 → $2.5 | Downgrades | Buy → Hold |
| 07/07/2022 | — | Alliance Global Partners | Downgrades | Buy → Neutral | |
| 07/07/2022 | — | BTIG | Downgrades | Buy → Neutral | |
| 02/18/2022 | 561% | Alliance Global Partners | → $0.7 | Upgrades | Neutral → Buy |
| 01/27/2021 | 2166.29% | Alliance Global Partners | $2.6 → $2.4 | Downgrades | Buy → Neutral |
| 01/27/2021 | 2732.86% | SVB Leerink | $4 → $3 | Maintains | Outperform |
| 11/05/2020 | 3205% | Canaccord Genuity | $4 → $3.5 | Maintains | Buy |
| 11/05/2020 | 3677.15% | SVB Leerink | $3 → $4 | Maintains | Outperform |
| 10/08/2020 | 2260.72% | BTIG | → $2.5 | Initiates Coverage On | → Buy |
| 08/12/2020 | 2732.86% | SVB Leerink | $2 → $3 | Maintains | Outperform |
| 07/16/2020 | 3677.15% | Canaccord Genuity | $3 → $4 | Maintains | Buy |
| 05/06/2020 | 1788.57% | SVB Leerink | $5 → $2 | Reiterates | → Outperform |
| 11/26/2019 | — | Janney Montgomery Scott | Downgrades | Buy → Neutral | |
| 09/12/2019 | 4621.44% | SVB Leerink | $3 → $5 | Reiterates | → Outperform |
| 09/12/2019 | — | Janney Montgomery Scott | Upgrades | Neutral → Buy | |
| 08/01/2019 | 277.71% | Alliance Global Partners | $5 → $0.4 | Downgrades | Buy → Neutral |
| 07/31/2019 | — | HC Wainwright & Co. | Downgrades | Buy → Neutral | |
| 07/31/2019 | — | Janney Montgomery Scott | Downgrades | Buy → Neutral | |
| 05/16/2019 | 4621.44% | Alliance Global Partners | → $5 | Initiates Coverage On | → Buy |
What is the target price for T2 Biosystems (TTOO)?
The latest price target for T2 Biosystems (NASDAQ: TTOO) was reported by Alliance Global Partners on July 13, 2023. The analyst firm set a price target for $0.07 expecting TTOO to fall to within 12 months (a possible -33.90% downside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for T2 Biosystems (TTOO)?
The latest analyst rating for T2 Biosystems (NASDAQ: TTOO) was provided by Alliance Global Partners, and T2 Biosystems maintained their neutral rating.
When is the next analyst rating going to be posted or updated for T2 Biosystems (TTOO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of T2 Biosystems, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for T2 Biosystems was filed on July 13, 2023 so you should expect the next rating to be made available sometime around July 13, 2024.
Is the Analyst Rating T2 Biosystems (TTOO) correct?
While ratings are subjective and will change, the latest T2 Biosystems (TTOO) rating was a maintained with a price target of $0.12 to $0.07. The current price T2 Biosystems (TTOO) is trading at is $0.11, which is out of the analyst's predicted range.
